No Cover Image

Journal article 520 views 70 downloads

Ruthenium(II) Polypyridyl Complexes as FRET Donors: Structure- and Sequence-Selective DNA-Binding and Anticancer Properties

Chris Elgar, Nur Aininie Yusoh, Paul Tiley, Natalia Kolozsvari, Laura G. Bennett, Amelia Gamble, Emmanuel Pean, Matthew Davies Orcid Logo, Christopher J. Staples, Haslina Ahmad, Martin Gill Orcid Logo

Journal of the American Chemical Society, Volume: 145, Issue: 2, Pages: 1236 - 1246

Swansea University Authors: Chris Elgar, Paul Tiley, Natalia Kolozsvari, Emmanuel Pean, Matthew Davies Orcid Logo, Martin Gill Orcid Logo

  • 62216.pdf

    PDF | Version of Record

    Released under the terms of a Creative Commons Attribution 4.0 International (CC BY 4.0) License.

    Download (4.28MB)

Check full text

DOI (Published version): 10.1021/jacs.2c11111

Abstract

Ruthenium(II) polypyridyl complexes (RPCs) that emit from metal-to-ligand charge transfer (MLCT) states have been developed as DNA probes and are being examined as potential anticancer agents. Here, we report that MLCT-emissive RPCs that bind DNA undergo Förster resonance energy transfer (FRET) with...

Full description

Published in: Journal of the American Chemical Society
ISSN: 0002-7863 1520-5126
Published: American Chemical Society (ACS) 2023
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa62216
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: Ruthenium(II) polypyridyl complexes (RPCs) that emit from metal-to-ligand charge transfer (MLCT) states have been developed as DNA probes and are being examined as potential anticancer agents. Here, we report that MLCT-emissive RPCs that bind DNA undergo Förster resonance energy transfer (FRET) with Cy5.5-labeled DNA, forming mega-Stokes shift FRET pairs. Based on this discovery, we developed a simple and rapid FRET binding assay to examine DNA-binding interactions of RPCs with diverse photophysical properties, including non-“light switch” complexes [Ru(dppz)2(5,5′dmb)]2+ and [Ru(PIP)2(5,5′dmb)]2+ (dppz = dipyridophenazine, 5,5′dmb = 5,5′-dimethyl-2,2′-bipyridine, PIP = 2-phenyl-imidazo[4,5-f][1,10]phenanthroline). Binding affinities toward duplex, G-quadruplex, three-way junction, and mismatch DNA were determined, and derived FRET donor–acceptor proximities provide information on potential binding sites. Molecules characterized by this method demonstrate encouraging anticancer properties, including synergy with the PARP inhibitor Olaparib, and mechanistic studies indicate that [Ru(PIP)2(5,5′dmb)]2+ acts to block DNA replication fork progression.
College: Faculty of Science and Engineering
Funders: Llywodraeth Cymru - 80761-SU-242; Royal Society of Chemistry - R20-8717, E21-9540096197
Issue: 2
Start Page: 1236
End Page: 1246